|
State of Califomia-Health and Welfare Agency
<br />ri
<br />Z_
<br />�.�:atitl' Itr% 1 Its:
<br />El
<br />Department of Health Services
<br />License Number. 1812-39
<br />Amendment Number: 47
<br />C. Group 3 Reagent kits including Ma/Tc 99m and Rb/Kr 8 1 m generators and utilizing bulk technetium
<br />prepared by a radiopharmacy for preparation of radiopharmaceuticals listed in Group 2.
<br />D. Group 4 Internal therapy not usually requiring hospitalization.
<br />E. Group 5 Internal therapy requiring hospitalization for purposes of radiation safety.
<br />F. Group 6 Brachytherapy and Ophthalmic treatments utilizing sealed or solid sources manufactured
<br />labeled, packaged, and distributed in accordance with a specific license issued pursuant to Title
<br />10, Code of Federal Regulations, Part 32.74, or a specific license issued by an agreement state
<br />pursuant to equivalent state regulations (except for sources manufactured prior to August 16,
<br />1974).
<br />L-5. Brachytherapy
<br />6. Applicator
<br />G. Group 9 Nonhuman use: Marker and calibration sources.
<br />WWX�Aygwi
<br />10. Radioactive material shall be used only at the following locations:
<br />(a) 525 West Acacia Street, Stockton, CA
<br />11. This license is subject to an annual fee for sources of radioactive material authorized to be possessed at any
<br />one time as specified in Item 6, 7, 8 and 9 of this license. The annual fee for this license is required by and
<br />computed in accordance with Title 17, California Code of Regulations, Sections 30230-30232 and is also
<br />subject to an annual cost -of -living adjustment pursuant to Section 100425 of the California Health and Safety
<br />Code.
<br />12. The individuals named below are authorized the specific uses of radioactive material described in Items 6, 7,
<br />8 and 9 of this license as follows:
<br />(a) AnU K. Sain, NLD.
<br />(b) Michael G. Khoury, M.D.
<br />(c) Michael D. Reitz, M.D.
<br />(d) James D. Rooke, M.D.
<br />(e) John B. Irish, M.D.
<br />(f) Jerome I. Bookin, M.D.
<br />(g) Chull S. Song, NLD.
<br />(h) Edward C. Greenleaf, M.D.
<br />(i) Bolar Rama Rao, MD.
<br />0) Dr. Dave Bernard, M.D.
<br />(l) Sam Kokoris, NLD.
<br />Groups 1, 2, 3, 4, and 9
<br />Groups 1, 2, 3, and 9
<br />Groups 1, 2, 3, 4 (except colloidal P-32), 5, and 9
<br />Groups 4 (Thyroid therapy only) and 5
<br />Group 6 (Strontium 90 only)
<br />Group 6 (Strontium 90 only)
<br />Groups 1, 2, 3, 6 (Strontium 90 only), and 9
<br />Group 6
<br />Groups 1, 2, 3, 4, 5, and 9
<br />Groups 1, 2, 3, 4, 5, and 9
<br />Groups 1, 2, 3, (4 and 5, 1-131 only) and 9
<br />
|